Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery GATA3
Path
Created with Sketch.
Go to GATA3 Normal Tissue Gallery
Go back to Product Page
Breast - Breast cancer of no special type (NST) showing moderate to strong GATA3 immunostaining. (GATA3 immunohistochemistry)
Breast – Breast cancer of no special type (NST) showing moderate to strong GATA3 immunostaining. (GATA3 immunohistochemistry)
Breast - Invasive lobular breast cancer showing moderate to strong GATA3 immunostaining. (GATA3 immunohistochemistry)
Breast – Invasive lobular breast cancer showing moderate to strong GATA3 immunostaining. (GATA3 immunohistochemistry)
Breast - Strong GATA3 immunostaining in a breast cancer of no special type (NST). (GATA3 immunohistochemistry)
Breast – Strong GATA3 immunostaining in a breast cancer of no special type (NST). (GATA3 immunohistochemistry)
Colon - Neuroendocrine carcinoma with weak to moderate GATA3 immunostaining in most tumor cells. (GATA3 immunohistochemistry)
Colon – Neuroendocrine carcinoma with weak to moderate GATA3 immunostaining in most tumor cells.
Kidney - GATA3 negative clear cell renal cell carcinoma. (GATA3 immunohistochemistry)
Kidney – GATA3 negative clear cell renal cell carcinoma. (GATA3 immunohistochemistry)
Kidney - GATA3 negative papillary renal cell carcinoma. (GATA3 immunohistochemistry)
Kidney – GATA3 negative papillary renal cell carcinoma. (GATA3 immunohistochemistry)
Liver - GATA3 negative hepatocellular carcinoma. (GATA3 immunohistochemistry)
Liver – GATA3 negative hepatocellular carcinoma.
Lung - GATA3 negative small cell carcinoma. (GATA3 immunohistochemistry)
Lung – GATA3 negative small cell carcinoma. (GATA3 immunohistochemistry)
Lymph node - Weak to moderate GATA3 immunostaining of lymphocytes in a case of T-ALL. (GATA3 immunohistochemistry)
Lymph node – Weak to moderate GATA3 immunostaining of lymphocytes in a case of T-ALL. (GATA3 immunohistochemistry)
Lymph node - Weak to moderate GATA3 immunostaining of lymphocytes in an angioimmunoblasic T-cell lymphoma. (GATA3 immunohistochemistry)
Lymph node – Weak to moderate GATA3 immunostaining of lymphocytes in an angioimmunoblasic T-cell lymphoma. (GATA3 immunohistochemistry)
Ovary - GATA3 negative serous high-grade carcinoma. (GATA3 immunohistochemistry)
Ovary – GATA3 negative serous high-grade carcinoma. (GATA3 immunohistochemistry)
Pleura - Weak GATA3 immunostaining in a fraction of cells in a malignant (epitheloid) mesothelioma. (GATA3 immunohistochemistry)
Pleura – Weak GATA3 immunostaining in a fraction of cells in a malignant (epitheloid) mesothelioma. (GATA3 immunohistochemistry)
Prostate - GATA3 negative adenocarcinoma of the prostate (Gleason 5+5=10). (GATA3 immunohistochemistry)
Prostate – GATA3 negative adenocarcinoma of the prostate (Gleason 5+5=10). (GATA3 immunohistochemistry)
Skin - Squamous cell carcinoma with weak GATA3 immunostaining in a fraction of tumor cells. (GATA3 immunohistochemistry)
Skin – Squamous cell carcinoma with weak GATA3 immunostaining in a fraction of tumor cells. (GATA3 immunohistochemistry)
Testis - Teratoma showing a weak to moderate GATA3 immunostaining in sebaceous and ekkrine glands. (GATA3 immunohistochemistry)
Testis – Teratoma showing a weak to moderate GATA3 immunostaining in sebaceous and ekkrine glands. (GATA3 immunohistochemistry)
Urinary bladder - Muscle-invasive urothelial carcinoma with moderate to strong GATA3 immunostaining of tumor cells. (GATA3 immunohistochemistry)
Urinary bladder – Muscle-invasive urothelial carcinoma with moderate to strong GATA3 immunostaining of tumor cells. (GATA3 immunohistochemistry)
Urinary bladder - Muscle-invasive urothelial carcinoma with moderate to strong GATA3 positivity of tumor cells. (GATA3 immunohistochemistry)
Urinary bladder – Muscle-invasive urothelial carcinoma with moderate to strong GATA3 positivity of tumor cells. (GATA3 immunohistochemistry)
Urinary bladder - Non-invasive papillary urothelial carcinoma (pTa, low grade) with strong GATA3 positivity of all tumor cells. (GATA3 immunohistochemistry)
Urinary bladder – Non-invasive papillary urothelial carcinoma (pTa, low grade) with strong GATA3 positivity of all tumor cells. (GATA3 immunohistochemistry)
Uterine cervix - Squamous cell carcinoma showing a weak GATA3 immunostaining in most tumor cells. (GATA3 immunohistochemistry)
Uterine cervix – Squamous cell carcinoma showing a weak GATA3 immunostaining in most tumor cells. (GATA3 immunohistochemistry)
Uterus - GATA3 negative serous endometrium carcinoma. (GATA3 immunohistochemistry)
Uterus – GATA3 negative serous endometrium carcinoma. (GATA3 immunohistochemistry)